Advances in Machine Learning-Enhanced PBPK Models for Brain-Targeted Drug Delivery via Nanocarriers: A Comprehensive Review
Journal of Functional Biomaterials · 03.08.2026 · 17 (8) · 377
DOI: 10.3390/jfb17080377 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 03.08.2026. Verfasst von Hanwen Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: J. Mike Walker '66 Department of Mechanical Engineering, Texas A&M University, College Station, TX 77843, USA. Die Arbeit nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. National Science Foundation.
Abstract (Originalsprache)
Nanostructured drug-delivery materials—liposomes, polymeric nanoparticles, dendrimers, and inorganic carriers—have become central to pharmaceutical strategies for crossing the blood–brain barrier (BBB), where most candidate therapeutics fail to reach their targets. Their biological performance hinges on a coupled chain of vascular transport, BBB translocation, tissue diffusion, cellular uptake, and intracellular release, each of which is shaped by the nanocarrier’s size, surface chemistry, charge, and ligand functionalization. Physiologically based pharmacokinetic (PBPK) models describe this chain mechanistically but are limited by parameter uncertainty, simplified representations of the BBB, and coarse regional resolution. Machine learning (ML) can close these gaps by extracting nonlinear structure–transport–exposure relationships from heterogeneous experimental and clinical datasets. This review examines emerging ML–PBPK hybrid frameworks for predicting the brain biodistribution of nanostructured drug carriers. We compare regression, kernel, and deep learning approaches for parameter inference, model correction, and surrogate modeling; assess strategies for feature selection, uncertainty quantification, and interpretability; and discuss documented failure cases that bound the conditions under which these methods can be trusted. The review closes with recommendations on dataset standardization, software platform selection, and the responsible use of generative AI in pharmaceutical modeling, thus providing guidance for translating nanostructured material design into safer, more effective brain-targeted therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- J. Mike Walker '66 Department of Mechanical Engineering, Texas A&M University, College Station, TX 77843, USA.
- Department of Electrical and Computer Engineering, Texas A&M University, College Station, TX 77843, USA.
- Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA.
- Department of Computer Science and Engineering, Texas A&M University, College Station, TX 77843, USA.
ORCID-Profile: Hanwen Hu
Förderung
- U.S. National Science Foundation
Zitieren
APA
Hu, H., & Wang, Y. (2026). Advances in Machine Learning-Enhanced PBPK Models for Brain-Targeted Drug Delivery via Nanocarriers: A Comprehensive Review. Journal of Functional Biomaterials, 17(8), 377. https://doi.org/10.3390/jfb17080377
Vancouver
Hu H, Wang Y. Advances in Machine Learning-Enhanced PBPK Models for Brain-Targeted Drug Delivery via Nanocarriers: A Comprehensive Review. Journal of Functional Biomaterials. 2026;17(8):377. doi:10.3390/jfb17080377
BibTeX
@article{Hu2026,
author = {Hu, Hanwen and Wang, Ya},
title = {Advances in Machine Learning-Enhanced PBPK Models for Brain-Targeted Drug Delivery via Nanocarriers: A Comprehensive Review},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {8},
pages = {377},
doi = {10.3390/jfb17080377}
}
EUVIMED